참고문헌
- State Administration of Traditional Chinese Medicine "The Chinese Materia Medica" the editorial board. "The Chinese Materia Medica" (volume 8). 1st ed. Shanghai : Shanghai science and Technology Press. 1999 : 482-5, 640.
- Chang XQ, Ding LX. "Manual analysis of active components in traditional Chinese Medicine"(volume 2). 1st ed. Beijing : Academic Press. 2002 : 1354-60.
- Shen YJ. Pharmacology of traditional Chinese Medicine. 1st ed. Beijing : People's Medical Publishing House. 2000:645-6.
- State Administration of Traditional Chinese Medicine "The Chinese Materia Medica" the editorial board. "The Chinese Materia Medica" (volume 1). 1st ed. Shanghai : Shanghai science and Technology Press. 1999 : 453-9.
- Chang XQ, Ding LX. Manual analysis of active components in traditional Chinese Medicine (volume 1). 1st ed. Beijing : Academic Press. 2002 : 1254-6.
- Wang YS, Deng WL, Xue CS. The application and pharmacology of traditional Chinese Medicine. 2nd ed. Beijing : People's Medical Publishing House. 2000 : 684-8.
- Odunsi ST, Vazquez-Roque MI, Camilleri M, Papathanasopoulos A, Clark MM, Wodrich L, Lempke M, McKinzie S, Ryks M, Burton D, Zinsmeister AR. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring). 2010 ; 18(8) : 1579-84. https://doi.org/10.1038/oby.2009.421
- Georg Jensen M, Kristensen M, Astrup A. Effect of alginate supplementation on weight loss in obese subjects completing a 12-wk energy-restricted diet: a randomized controlled trial. Am J Clin Nutr. 2012 ; 96(1) : 5-13. https://doi.org/10.3945/ajcn.111.025312
- Georg Jensen M, Pedersen C, Kristensen M, Frost G, Astrup A. Review: efficacy of alginate supplementation in relation to appetite regulation and metabolic risk factors: evidence from animal and human studies. Obes Rev. 2013 ; 14(2) : 129-44. https://doi.org/10.1111/j.1467-789X.2012.01056.x
- Keithley J, Swanson B. Glucomannan and obesity; a critical review. Altern Ther Health Med. 2005 ; 11(6) : 30-4.
- Cairella M, Marchini G. Evaluation of the action of glucomannan on metabolic parameters and on the sensation of satiation in overweight and obese patients. Clin Ter. 1995 ; 146(4) : 269-74.
- Vita PM, Restelli A, Caspani P, Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med. 1992 ; 83(3) : 135-9.
- Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984 ; 8(4) : 289-93.
- Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003 ; 37(5) : 1202-19.
- Jun DW, Influence of dietary intake on non-alcoholic fatty liver disease in Korean. National Institute of Food and Drug Safety Evaluation. 2012 : 12.
- Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond). 2009 ; 116(7) : 539-64. https://doi.org/10.1042/CS20080253
- Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008 ; 28(4) : 339-50. https://doi.org/10.1055/s-0028-1091978
- Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009 ; 50(1) : 204-10. https://doi.org/10.1016/j.jhep.2008.10.010
- Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care. 2007 ; 30(8) : 2119-21. https://doi.org/10.2337/dc07-0349
- Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, Kawahito Y, Yoshida N, Suetsugu A, Kato T, Okuda J, Ida K, Yoshikawa T. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007 ; 13(10) : 1579-84. https://doi.org/10.3748/wjg.v13.i10.1579
- Oh JS, Lee SR, Hwang KT, Ji GE. The Anti-Obesity Effects of the Dietary Combination of Fermented Red Ginseng with Levan in High Fat Diet Mouse Model. Phytother Res. 2013 ; 19 : 1-6.
- Garrido-Polonio C, Garcia-Linares MC, Garcia -Arias MT, Lopez-Varela S, Garcia-Fernandez MC, Terpstra AH, Sanchez-Muniz FJ.. Thermally oxidised sunflower-seed oil increases liver and serum peroxidation and modifies lipoprotein composition in rats. Br J Nutr. 2004 ; 92(2) : 257-65. https://doi.org/10.1079/BJN20041174
- Clark JM, Brancati FL, Diehl AM. The sprevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003 ; 98(5) : 960-7. https://doi.org/10.1111/j.1572-0241.2003.07486.x
- Westerbacka J, Corner A, Tiikkainen M, Tamminen M, Vehkavaara S, Hakkinen AM, Fredriksson J, Yki-Jarvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004 ; 47(8) : 1360-9.
- Fraser A, Longnecker MP, Lawlor DA. Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007 ; 133(6) : 1814-20. https://doi.org/10.1053/j.gastro.2007.08.077
- Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008 ; 47(4) : 1363-70. https://doi.org/10.1002/hep.22109